| Ashley Piccone, AUD | |
|
3805 Yellow Pine Pl, Loveland, CO 80538-8904 | |
| (720) 333-3956 | |
| Not Available |
| Full Name | Ashley Piccone |
|---|---|
| Gender | Female |
| Speciality | Audiologist |
| Location | 3805 Yellow Pine Pl, Loveland, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144708892 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | AUD.0000459 (Colorado) | Primary |
| Provider Name | Stinson Mobile Aud Nc Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1912472945 PECOS PAC ID: 6608120274 Enrollment ID: O20181117000009 |
News Archive
Research aimed at teasing apart the workings of RNA enzymes eventually may lead to ways of monitoring fat metabolism and might even assist in the search for signs of life on Mars, according to University of Michigan researcher Nils Walter.
Shire plc, the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) has assigned a Prescription Drug User Fee Act (PDUFA) date of August 25, 2011 for the review of the New Drug Application (NDA) for FIRAZYR(R) (icatibant) for the treatment of acute attacks (Types I and II) of hereditary angioedema (HAE). This 6 month review timeline is consistent with review as a Class II resubmission.
A research study led by the Peninsula College of Medicine and Dentistry, University of Exeter, and Boston University School of Medicine, in collaboration with a global consortium, has identified genetic markers that influence a protein involved in regulating oestrogen and testosterone levels in the bloodstream.
New research published Online First in The Lancet indicates that babies born to mothers who are overweight or obese in sub-Saharan Africa, where rates of obesity are projected to increase at an alarming rate during the next two decades, are significantly more likely to die in the first two days after their birth. The study is the first to shed light on the role of maternal obesity in neonatal death (during the first 28 days of life) in developing countries.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Piccone, AUD 3805 Yellow Pine Pl, Loveland, CO 80538-8904 Ph: (720) 355-3956 | Ashley Piccone, AUD 3805 Yellow Pine Pl, Loveland, CO 80538-8904 Ph: (720) 333-3956 |
News Archive
Research aimed at teasing apart the workings of RNA enzymes eventually may lead to ways of monitoring fat metabolism and might even assist in the search for signs of life on Mars, according to University of Michigan researcher Nils Walter.
Shire plc, the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) has assigned a Prescription Drug User Fee Act (PDUFA) date of August 25, 2011 for the review of the New Drug Application (NDA) for FIRAZYR(R) (icatibant) for the treatment of acute attacks (Types I and II) of hereditary angioedema (HAE). This 6 month review timeline is consistent with review as a Class II resubmission.
A research study led by the Peninsula College of Medicine and Dentistry, University of Exeter, and Boston University School of Medicine, in collaboration with a global consortium, has identified genetic markers that influence a protein involved in regulating oestrogen and testosterone levels in the bloodstream.
New research published Online First in The Lancet indicates that babies born to mothers who are overweight or obese in sub-Saharan Africa, where rates of obesity are projected to increase at an alarming rate during the next two decades, are significantly more likely to die in the first two days after their birth. The study is the first to shed light on the role of maternal obesity in neonatal death (during the first 28 days of life) in developing countries.
› Verified 7 days ago
Sara Lynne Nulle, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 4575 Byrd Dr, Loveland, CO 80538 Phone: 719-963-7527 | |
Andrea Lee Hardy, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2980 Ginnala Dr, Unit 102, Loveland, CO 80538 Phone: 970-593-9700 Fax: 970-593-9712 | |
Whitney Swander Audiology Inc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2902 Ginnala Dr Ste 3, Loveland, CO 80538 Phone: 970-593-1509 | |
Audiology & Hearing Aid Center Of Northern Colorado Audiologist Medicare: Not Enrolled in Medicare Practice Location: 909 E Eisenhower Blvd, #101, Loveland, CO 80537 Phone: 970-593-9137 | |
Hearing Rehabilitation Center Inc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2980 Ginnala Dr, Unit 102, Loveland, CO 80538 Phone: 970-593-9700 Fax: 970-593-9712 | |
Tondalao Delee Johnson, M.S., CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 909 E Eisenhower Blvd, Loveland, CO 80537 Phone: 970-593-9137 Fax: 970-593-9137 |